An immune checkpoint inhibitor (a monoclonal antibody) is shown activating a T cell (blue) to attack a cancer cell (green). While checkpoint inhibitors represent an important class of anticancer agent, their use sometimes results in immune cells damaging normal tissue.
Keywords: 3D, Editorial, Allergy / Immunology, Anatomy, Cell biology / Histology, Disease Management, General Medicine, Molecular Biology, Oncology, Pathology
© Linda Nye